MRK vs PANW: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Palo Alto Networks, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
VS
Palo Alto Networks, Inc. · Technology
$287.78
+2.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
PANW has more upside to fair value
(+2.9%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
PANW |
| Current Price |
$113.87 |
$287.78 |
| Fair Value Estimate |
$100.14 |
$296.19 |
| Upside to Fair Value |
-12.1%
|
+2.9%
|
| Market Cap |
$281.2B |
$196.1B |
| Forward P/E |
32.0x
|
248.9x
|
| EV / EBITDA |
17.3x
|
85.9x
|
| Price / Sales |
4.3x
|
18.5x
|
| Price / FCF |
19.9x
|
45.7x
|
| Revenue Growth YoY |
+4.3%
|
+31.1%
|
| Gross Margin |
75.9%
|
71.9%
|
| Operating Margin |
27.6%
|
9.6%
|
| Return on Equity |
17.9%
|
6.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.02%
|
2.19%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Palo Alto Networks is a leading cybersecurity company specializing in next-generation security platforms with a strong subscription and support revenue base comprising approximately 81% of total revenue. The company benefits from a wide and expanding competitive moat driven by its AI- and platform-driven cybersecurity solutions, led by a seasoned management team. Despite strong revenue growth of …
Accumulation Zones
| Metric |
MRK |
PANW |
| Zone Low |
$75.11 |
$222.14 |
| Zone High |
$85.12 |
$251.76 |
| In Buy Zone? |
No
|
No
|